Health Care Deal News - February, 4, 2013 - HCC Best Practices for Proactive Medical Management, Pernix Therapeutics Holdings Inc. (NYSE: PTX) is Another Company on an Acquisition Roll

 

Brought to you by www.DealSearchOnline.com
 

February 4, 2013 Issue:

 

  1. Recent Health Care M&A Deals 
  2. Spotlight On: Pharmaceuticals
  3. Spotlight on: Medical Devices
  4. Webcast Calendar

Recent Health Care M&A Deals

HOSPITALS

Acquirer

Target

Price

 Bangkok Dusit Medical Services

 Krungdhon Hospital

 $23.4 million

LABORATORIES, MRI AND DIALYSIS

Acquirer

Target

Price

 JLL Partners

 Bioclinica, Inc and CoreLab Partners

 $123 million for Bioclinica

MEDICAL DEVICES

Acquirer

Target

Price

 Solta Medical, Inc.

 Sound Surgical

 $30.5 million

PHARMACEUTICALS

Acquirer

Target

Price

 Pharmascience

 Rivex Pharma division

 up to $8.5 million

 Del Mar Pharmaceuticals (BC) Ltd.

 DelMar Pharmaceuticals, Inc.

 $1.83 million

 

HCC Best Practices for Proactive Medical Management
March 18-19, 2013 - Sheraton Music City Hotel - Nashville, TN
We are pleased to announce our 4th Annual HCC Best Practices conference. This conference will build on the success of the 2011 and 2012 conferences while providing practical, timely updates to help you continue to evolve your medical management practices with sound HCC coding.

www.opalevents.org/trk/hccb1301.html

 

Spotlight on: Pharmaceuticals
Pernix Therapeutics Holdings Inc. (NYSE: PTX) is another company on an acquisition roll. Following its November announcement of a dual purchase—Cypress Pharmaceuticals and Hawthorn Pharmaceuticals—Pernix announced its $25 million, stock-for-stock bid for Somaxon Pharmaceuticals, Inc.......Read more

 

NEW- The Health Care Services Acquisition Report, 19th Edition - Preorder Today!
Deals have been made. The 2013 Health Care Services Acquisition Report contains private deals in this market that are too small to make it into the financial press. Take advantage of our limited 2-for-1 offer - preorder The 2013 Health Care Services Acquisition Report by March 31st  and receive The 2012 Health Care Services Acquisition Report FREE ($595 value)! Now that’s a recession resistant deal. Go to http://www.levinassociates.com/hardescription or call 800-248-1668 to preorder today!

 

Spotlight on: Medical Devices
With more than 2 million patients on some form of dialysis around the world, and dialysis treatment rates rising more than 5% annually, it isn’t hard to discern the reasoning behind Baxter International’s (NYSE: BAX) $4 billion bid for Gambro AB, a privately held dialysis product company based in Lund, Sweden.....Read more

 
Conference Calendar...Click here to see more